0001928983-22-000001.txt : 20220518 0001928983-22-000001.hdr.sgml : 20220518 20220518122710 ACCESSION NUMBER: 0001928983-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 EFFECTIVENESS DATE: 20220518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Resilient Lifescience, Inc. CENTRAL INDEX KEY: 0001928983 IRS NUMBER: 881992993 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446068 FILM NUMBER: 22937822 BUSINESS ADDRESS: STREET 1: 1000 S. COMMONS STREET 2: UNIT 102 CITY: PITTSBURGH STATE: PA ZIP: 15212 BUSINESS PHONE: 978-407-1703 MAIL ADDRESS: STREET 1: 1000 S. COMMONS STREET 2: UNIT 102 CITY: PITTSBURGH STATE: PA ZIP: 15212 D 1 primary_doc.xml X0708 D LIVE 0001928983 Resilient Lifescience, Inc. 100 S. COMMONS UNIT 102 PITTSBURGH PA PENNSYLVANIA 15212 978-407-1703 DELAWARE None None Corporation true 2022 Bradford Holden 100 S. Commons Unit 102 Pittsburgh PA PENNSYLVANIA 15212 Executive Officer Director Chief Executive Officer and Treasurer Charles Proctor 100 S. Commons Unit 102 Pittsburgh PA PENNSYLVANIA 15212 Executive Officer Director Secretary Other Health Care Decline to Disclose 06b false 2022-05-04 false true Simple Agreements for Future Equity (SAFEs) false 0 240000 75000 165000 false 2 0 0 42000 true Some proceeds will be used for working capital and general corporate needs, which may include director and officer compensation. false Resilient Lifescience, Inc. /s/ Bradford Holden Bradford Holden Chief Executive Officer 2022-05-18